3.61
0.84%
0.03
Pre-mercato:
3.61
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.58
Aprire:
$3.6
Volume 24 ore:
523.76K
Relative Volume:
0.74
Capitalizzazione di mercato:
$269.28M
Reddito:
$405.47M
Utile/perdita netta:
$53.66M
Rapporto P/E:
6.2241
EPS:
0.58
Flusso di cassa netto:
$131.28M
1 W Prestazione:
-2.17%
1M Prestazione:
-5.00%
6M Prestazione:
-15.26%
1 anno Prestazione:
-55.98%
Orasure Technologies Inc Stock (OSUR) Company Profile
Nome
Orasure Technologies Inc
Settore
Industria
Telefono
(503) 641-6115
Indirizzo
220 E FIRST ST, BETHLEHEM, PA
Confronta OSUR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.61 | 269.28M | 405.47M | 53.66M | 131.28M | 0.72 |
ISRG
Intuitive Surgical Inc
|
521.96 | 185.91B | 7.87B | 2.24B | 586.00M | 6.22 |
BDX
Becton Dickinson Co
|
226.87 | 65.59B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
84.89 | 41.99B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
228.69 | 33.57B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
327.56 | 23.72B | 2.88B | 499.60M | 321.60M | 6.74 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-01-03 | Ripresa | Evercore ISI | In-line |
2021-09-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
2020-08-21 | Iniziato | Evercore ISI | Outperform |
2020-08-10 | Iniziato | Citigroup | Buy |
2020-08-10 | Iniziato | JP Morgan | Neutral |
2020-08-07 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-06-25 | Iniziato | Lake Street | Buy |
2020-04-21 | Ripresa | Stephens | Equal-Weight |
2018-10-23 | Ripresa | Raymond James | Mkt Perform |
2018-07-16 | Downgrade | Stephens | Overweight → Equal-Weight |
2017-11-02 | Downgrade | Jefferies | Buy → Hold |
2017-02-09 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2016-06-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
2015-11-05 | Reiterato | Mizuho | Buy |
2015-05-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
2015-01-23 | Reiterato | Mizuho | Buy |
2014-06-12 | Reiterato | Canaccord Genuity | Buy |
2014-06-11 | Reiterato | Mizuho | Buy |
2012-12-21 | Iniziato | Mizuho | Buy |
2012-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2012-07-05 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2012-03-27 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Orasure Technologies Inc Borsa (OSUR) Ultime notizie
OraSure Technologies (NASDAQ:OSUR) Upgraded by StockNews.com to Buy Rating - Defense World
OraSure Technologies (NASDAQ:OSUR) Upgraded at StockNews.com - MarketBeat
Barclays PLC Raises Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Jane Street Group LLC - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Franklin Resources Inc. - Defense World
OraSure Technologies Completes Acquisition of Sherlock Biosciences, Inc. - Defense World
State Street Corp Sells 257,093 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
State Street Corp Has $7.48 Million Stock Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) - MarketBeat
OraSure stock hits 52-week low at $3.58 amid market challenges - Investing.com Nigeria
OraSure stock hits 52-week low at $3.58 amid market challenges By Investing.com - Investing.com South Africa
OSUR Stock Rises Following the Acquisition of Sherlock Biosciences - MSN
FDA Approves Premarket Approval Application for OraQuick HIV Self-Test, Expanding Access to Adolescents - Pharmacy Times
OraSure Tech stock hits 52-week low at $3.7 amid challenges - Investing.com
OraSure acquires maker of over-the-counter STI tests - 69News WFMZ-TV
OraSure Tech stock hits 52-week low at $3.7 amid challenges By Investing.com - Investing.com South Africa
OraSure Technologies Acquires Sherlock Biosciences - The Manila Times
OraSure Expands Into $1.5B Molecular Testing Market with Sherlock Biosciences Acquisition - StockTitan
OraSure Technologies: Return To Profitability Is Uncertain (NASDAQ:OSUR) - Seeking Alpha
Short Interest in OraSure Technologies, Inc. (NASDAQ:OSUR) Grows By 17.3% - MarketBeat
Should Value Investors Buy biote Corp. (BTMD) Stock? - Yahoo Finance
Charles Schwab Investment Management Inc. Sells 48,005 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Orasure Technologies Inc (NASDAQ: OSUR): A Great Stock To Watch - Stocks Register
OraSure Technologies: Discounted Assets With An Attractive Free Call Option (NASDAQ:OSUR) - Seeking Alpha
OraSure Technologies, Inc. (NASDAQ:OSUR) Holdings Raised by Jacobs Levy Equity Management Inc. - MarketBeat
Walleye Capital LLC Acquires Shares of 195,452 OraSure Technologies, Inc. (NASDAQ:OSUR) - MarketBeat
OraSure Technologies, Inc. (NASDAQ:OSUR) Stock Holdings Boosted by Systematic Financial Management LP - MarketBeat
Over The Counter Testing Strategic Business Report 2024, with Profiles of 30+ Players Including i-Health Lab, LabStyle Innovations, NOWDiagnostics, OraSure Technologies, Roche Diagnostics and Sinocare - Yahoo Finance
BNP Paribas Financial Markets Acquires 183,191 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - MarketBeat
OSUR Stock Surges Over 5% Amid Mixed Financial Performance - GuruFocus.com
OraSure Receives Federal Funding For Development Of Marburg Virus Rapid Antigen Test - Barchart
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test - citybiz
OraSure secures $7.5 million BARDA contract for Marburg test - Investing.com
OraSure Technologies, Inc. Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test from Biomedical Advanced Research and Development Authority - Marketscreener.com
American Capital Management Inc. Trims Stake in OraSure Technologies, Inc. (NASDAQ:OSUR) - MarketBeat
Victory Capital Management Inc. Sells 14,323 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Is OraSure Technologies (OSUR) Stock Undervalued Right Now? - Yahoo Finance
Saliva Collection and Diagnostics Market Size Analysis and Top Companies - Precedence Research
Principal Financial Group Inc. Purchases 14,480 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Is OraSure Technologies (OSUR) a Great Value Stock Right Now? - MSN
Will Marketing Make the Difference for OraSure? - AOL
OraSure to Participate in Upcoming Investor Conference - The Manila Times
OraSure stock hits 52-week low at $3.91 amid market challenges - Investing.com
OraSure Technologies (OSUR) Reports Q3 Loss, Tops Revenue Estimates - MSN
Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings - Simply Wall St
There May Be Some Bright Spots In OraSure Technologies' (NASDAQ:OSUR) Earnings - Yahoo Finance
Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results - Simply Wall St
OraSure Technologies, Inc. (NASDAQ:OSUR) Q3 2024 Earnings Call Transcript - Insider Monkey
OraSure Technologies, Inc. (NASDAQ:OSUR) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance
OraSure Technologies Inc (OSUR) Q3 2024 Earnings Call Highlights - GuruFocus.com
Orasure Technologies Inc Azioni (OSUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):